Skip to content

Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy

Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05618535
Enrollment
100
Registered
2022-11-16
Start date
2022-12-01
Completion date
2023-06-30
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Brief summary

The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.

Detailed description

Hemodynamic stability can prevent hypoperfusion or hyperperfusion after reperfusion therapy. It has been reported in a large number of literatures that body position has an effect on hemodynamics, but the effect of different body positions on the hemodynamics of patients undergoing ultra-early reperfusion therapy is not clear. In this study, we hypothesized that the hemodynamics of patients undergoing ultra-early reperfusion therapy would differ between different positions.

Interventions

Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler.

Sponsors

Yi Yang
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age≥18 years, \< 80 years, regardless of sex; * Patients with clinically confirmed acute ischemic stroke who received intravenous thrombolysis or emergency endovascular treatment; * Baseline National Institute of Health stroke scale(NIHSS)score ≤25; * Baseline Glasgow Coma Scale (GCS) ≥8; * Signed and dated informed consent is obtained

Exclusion criteria

* The patient has clear indications or contraindications, such as active vomiting, spinal cord injury; * Clinicians considered that the assigned body position could not be maintained; Patients unable to cooperate with all noninvasive beat-by-beat continuous BP monitoring; * Poor temporal window penetration; * Patients with diseases that seriously affect hemodynamics, such as atrial fibrillation, anemia, and hyperthyroidism; * Previous history of atrial fibrillation or ECG showing atrial fibrillation or arrhythmia; * Pregnant or lactating women; * Poor treatment compliance; * Complicated with severe systemic diseases, such as heart failure, respiratory failure, renal failure, gastrointestinal bleeding, coagulopathy, malignant tumors.

Design outcomes

Primary

MeasureTime frameDescription
Differences in blood pressure variability(BPV)between different positions0-7 daysBPV is defined as blood pressure oscillations in relation to the mean values.
Differences in heart rate variability (HRV) between different positions0-7 daysHRV is defined as heart rate oscillations in relation to the mean values.

Secondary

MeasureTime frameDescription
The difference of middle cerebral artery blood flow velocity between different positions.0-7 daysContinuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026